NASDAQ:MNTL Tema Neuroscience and Mental Health ETF (MNTL) Price, Holdings, & News → The only AI company to buy (From Porter & Company) (Ad) Free MNTL Stock Alerts $24.54 +0.18 (+0.74%) (As of 05/31/2024 08:51 PM ET) Add Compare Share Share Today's Range$24.47▼$24.5450-Day Range$23.67▼$26.1452-Week Range$23.67▼$26.74Volume700 shsAverage Volume12,321 shsMarket Capitalization$10.80 millionAssets Under Management$10.70 millionDividend YieldN/ANet Expense Ratio0.75% Stock AnalysisStock AnalysisChartHoldingsTrendsStock AnalysisChartHoldingsTrends Get Tema Neuroscience and Mental Health ETF alerts: Email Address About Tema Neuroscience and Mental Health ETFThe Tema Neuroscience and Mental Health ETF (MNTL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, concentrating on companies engaged in addressing disorders of the central nervous system and mental health worldwide. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. MNTL was launched on Jan 22, 2024 and is issued by Tema.Read More MNTL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MNTL ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive MNTL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tema Neuroscience and Mental Health ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerTema Global Fund NameTema Neuroscience and Mental Health ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:MNTL Inception Date1/22/2024 Fund ManagerDavid Song, Yuri Khodjamirian WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings46 Fund Statistics Assets Under Management$10.70 million Average Daily Volume$0.00 Discount/Premium0.04% Administrator, Advisor and Custodian AdministratorUS Bancorp Fund Services, LLC AdvisorTema Global Limited CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentUS Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerOld Mission Miscellaneous Outstanding Shares440,000Beta0.99 Creation Unit10,000 Creation Fee$500.00 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Ad The Freeport SocietyNext President (Not Trump. Not Biden.)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________. Tema Neuroscience and Mental Health ETF ExpensesTypeMNTLTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.99%0.57%0.54%0.48%0.51%Other Expenses0.00%0.72%0.54%0.34%0.58%Total Expense0.99%0.72%0.70%0.58%0.70%Fee Waiver-0.24%-0.76%-0.55%-0.22%-0.56%Net Expense0.75%0.59%0.60%0.54%0.58% Tema Neuroscience and Mental Health ETF (MNTL) ExposureMNTL Sector ExposureMNTL Industry ExposureFull Holdings Details Similar ETFsVanEck Robotics ETFNASDAQ:IBOTStockSnips AI-Powered Sentiment US All Cap ETFNASDAQ:NEWZGlobal X Clean Water ETFNASDAQ:AQWAShort Duration Green Bond ETFNASDAQ:CCSBiShares ESG MSCI USA Min Vol Factor ETFNASDAQ:ESMV MNTL ETF - Frequently Asked Questions How have MNTL shares performed in 2024? Tema Neuroscience and Mental Health ETF's stock was trading at $25.49 at the start of the year. Since then, MNTL shares have decreased by 3.7% and is now trading at $24.54. View the best growth stocks for 2024 here. What does MNTL invest in? Tema Neuroscience and Mental Health ETF is a equity fund issued by Tema Global. MNTL focuses on theme investments. The fund's investments total to approximately $10.70 million assets under management. What is the management fee for Tema Neuroscience and Mental Health ETF? Tema Neuroscience and Mental Health ETF's management fee is 0.99% and has no other recorded expenses. However, MNTL has a fee waiver of -0.24% to reimburse the expenses. The net expense ratio for MNTL is 0.75%. How do I buy shares of Tema Neuroscience and Mental Health ETF? Shares of MNTL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MNTL) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBill Gates is all about this tiny $2 stockTimothy SykesBiden Nomination CANCELED?The Freeport SocietyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTradeShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden replacement revealed?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Neuroscience and Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.